` Comparison: WBA vs 3349 - Alpha Spread

WBA
vs
3349

Over the past 12 months, WBA has outperformed Cosmos Pharmaceutical Corp, delivering a return of +7% compared to the Cosmos Pharmaceutical Corp's 5% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
WBA
3349
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

WBA Intrinsic Value
HIDDEN
Show
Cosmos Pharmaceutical Corp Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Walgreens Boots Alliance Inc
NASDAQ:WBA
11.98 USD
Cosmos Pharmaceutical Corp
TSE:3349
6 941 JPY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
WBA, 3349

WBA
3349
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Walgreens Boots Alliance Inc
Revenue
Cosmos Pharmaceutical Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
WBA, 3349

WBA
3349
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Walgreens Boots Alliance Inc
NASDAQ:WBA
Cosmos Pharmaceutical Corp
TSE:3349
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

WBA
17.1%
Cosmos Pharmaceutical Corp
21.1%

Operating Margin

WBA
2.2%
Cosmos Pharmaceutical Corp
3.9%

Net Margin

WBA
-4.1%
Cosmos Pharmaceutical Corp
3%

FCF Margin

WBA
0.4%
Cosmos Pharmaceutical Corp
0%

ROE

WBA
-60.5%
Cosmos Pharmaceutical Corp
12.2%

ROA

WBA
-8.3%
Cosmos Pharmaceutical Corp
6.1%

ROIC

WBA
7.4%
Cosmos Pharmaceutical Corp
10.2%

ROCE

WBA
6.7%
Cosmos Pharmaceutical Corp
13.9%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
WBA, 3349

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
WBA, 3349

Performance Gap Between WBA and 3349
HIDDEN
Show

Performance By Year
WBA, 3349

Loading
WBA
3349
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare WBA to other stocks
CLS
Clicks Group Ltd
C
More expensive
vs WBA
DCP
Dis-Chem Pharmacies Ltd
D
More expensive
vs WBA
9776
Sapporo Clinical Laborat...
More expensive
vs WBA
RADL3
Raia Drogasil SA
More expensive
vs WBA
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett